Natural Antibodies Against Sialoglycans
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Natural antibodies, part of the innate immunity system, are produced at strictly regulated levels in normal sera without immunization and thus are part of the innate immune system. The best studied natural antibodies are those directed against blood group antigens A and B and xeno-antigens including glycolylneuraminic acid containing Hanganutziu-Deicher (HD) glycolipid. Abnormal levels of anti-glycan antibodies were found in a number of pathologies. In many cases pathological antibodies are known to bind gangliosides. The genesis of anti-glycan antibodies in healthy humans and the reasons for their changes in pathologies are poorly understood. With a growing interest in their diagnostic applications, it is important to determine the carbohydrate structures that are recognized by antibodies present in the circulation of healthy individuals. We tested a large number of healthy donors using a printed glycan array (PGA) in a microchip format. The PGA contained ~300 glycans, representing mostly normal mammalian structures of glycoproteins and glycolipids, and many of the structures presented are biologically relevant sialylated motifs. As revealed by PGA, the sera interacted with at least 70 normal human glycans. With only few exceptions, antibodies recognizing sialosides have not been identified. Moderate levels of antibodies and moderate variability were observed in the case of SiaT n and its glycolyl variant. Unexpectedly, we found minimal antibody titer directed against Neu5Gcα and the trisaccharide Neu5Gcα2-6Galβ1-4GlcNAc, although this form of neuraminic acid does not occur naturally in humans. Antibodies recognizing sialosides in unnatural β-configuration have been detected and confirmed Springer's paradigm that circulating antibodies represent a reaction against bacteria. Gram-negative bacteria contain LPS with βKDN and/or βKDO which are very close analogs of Neu5Ac that are found in β-connected form. Antibodies against the biantennary N-glycan chain, (Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα)2-3,6-Manβ1-4GlcNAcβ1-4GlcNAc were never observed and similarly we never saw antibodies directed against the SiaLe(a)/SiaLe (x) motifs. Anti-sialoglycan antibodies can be masked with gangliosides: for example, we observe about a five times higher level of anti-GD3 in purified total IgG compared to the same concentration of total Ig in the composition of native serum. For several antibodies we observed anomalous binding in diluted sera, namely, the signals towards sialylated glycans were increased in the PGA if diluted sera were used.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M. E., Alvarez, R., Bryan, M. C., Fazio, F., Calarese, D., Stevens, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407902101 · Cited by 1,101 · cited 1×
“Glycans of 95–98% purity (Lectinity Holdings, Moscow, Russia) were printed as previously described [19], at 50 μM concentration, with 8 or 16 replicates each.”
MethodSelf-citationT and Tn, General Carcinoma Autoantigens
Springer, G. F. (1984) · Science · doi:10.1126/science.6729450 · Cited by 1,009 · cited 2×
“Springer postulated that anti-glycan Ab appear in response to stimulation of the immune system by bacterial O-antigens and lipopolysaccharides (LPS) of gastrointestinal bacteria [5, 6].”
BackgroundNatural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
Avrameas, S. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80045-3 · Cited by 766 · cited 1×
“NAb are typically characterized by the presence ofmany arginine and lysine residues in their hypervariable regions [22] and many polyreactive NAb in fact tend to bind negatively charged antigens [23].”
BackgroundFukui, S., Feizi, T., Galustian, C., Lawson, A. M., & Chai, W. (2002) · Nature Biotechnology · doi:10.1038/nbt735 · Cited by 580 · cited 1×
“Development of PGA, a multi-hundred glycan array printed on a microchip platform [10, 18–20], offers a possibility for systematic, large-population based research [21].”
BackgroundPadler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Chen, X., & Varki, A. (2008) · Glycobiology · doi:10.1093/glycob/cwn072 · Cited by 326 · cited 1×
“There are many reports on the presence of antibodies against Neu5Gc in form of HD-antigen, with 2-3 bound glycolylneuraminic acid, Neu5Gcα2-3Galβ1-4Glc or Neu5Gcα2-3Galβ1-4GlcNAc [25, 26] in humans.”
BackgroundBlood group isoantibody stimulation in man by feeding blood group-active bacteria
Springer, G. F., & Horton, R. E. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106094 · Cited by 317 · cited 2×
“Springer postulated that anti-glycan Ab appear in response to stimulation of the immune system by bacterial O-antigens and lipopolysaccharides (LPS) of gastrointestinal bacteria [5, 6].”
BackgroundShoenfeld, Y., & Isenberg, D. A. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90245-4 · Cited by 288 · cited 2×
“These immunoglobulins (Ig) are called natural antibodies (NAb), since they are present in sera of all individuals in the absence of deliberate immunization [3], and are thus part of the innate immune system [4].”
BackgroundLewis Histo‐Blood Group System and Associated Secretory Phenotypes
Henry, S., Oriol, R., & Samuelsson, B. (1995) · Vox Sanguinis · doi:10.1111/j.1423-0410.1995.tb02591.x · Cited by 219 · cited 1×
“The biosynthetic precursor of these structures, Galβ1-3GlcNAc, is known as Le and is not significant for blood typing [27].”
BackgroundAnti-carbohydrate antibodies of normal sera: Findings, surprises and challenges
Huflejt, M. E., Vuskovic, M., Vasiliu, D., Xu, H., Obukhova, P., Shilova, N., Tuzikov, A., Galanina, O., Arun, B., Lu, K., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.06.010 · Cited by 186 · cited 10×
“The next group of charged glycans were molecules containing glucuronic acid, GlcA [21], and first of all the GlcAβ1-3Gal motif known to be a fragment of the Natural Antibodies Against Sialoglycans”
BackgroundMethodSelf-citationXenoantigens and xenoantibodies
Cooper, D. K. C. (1998) · Xenotransplantation · doi:10.1111/j.1399-3089.1998.tb00003.x · Cited by 139 · cited 1×
“The best known and studied NAb are directed to blood group antigens A and B [7], and to the xenoantigen Galα1-3Galβ1-4GlcNAc [8–10], Forssman (Fs) glycolipid antigen GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glc [11, 12], Hanganutziu–Deicher (HD) antigen Neu5Gcα2-3Galβ1-4Glc [13], and anti-ganglioside Ab.”
Background
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Indeed a significant fraction of circulating Ig found in normal humans may be directed against foreign glycan antigens (971) (972) (973) .”
BackgroundHolodick, N. E., Rodríguez-Zhurbenko, N., & Hernández, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00872 · Cited by 206
“In humans, the best known antiglycan antibodies react with blood group antigens A and B (57), the xenoantigen Gal-alpha-1,”
BackgroundDhar, C., Sasmal, A., & Varki, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00807 · Cited by 123
Immunoglobulin M: An Ancient Antiviral Weapon – Rediscovered
Gong, S., & Ruprecht, R. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01943 · Cited by 116
“Natural IgM is broadly reactive to not only protein but also non-protein antigens, such as phosphorylcholine (54), phosphatidylcholine (55), and glycans (56, 57).”
BackgroundSamraj, A. N., Bertrand, K. A., Luben, R., Khedri, Z., Yu, H., Nguyen, D., Gregg, C. J., Diaz, S. L., Sawyer, S., Chen, X., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197464 · Cited by 54
“It should also be noted that the majority of the sera showed IgGs at just detectable levels in both assays, consistent with a recent report by others who also “found minimal antibody titer directed against Neu5Gcα and the trisaccharide Neu5Gcα2–6Galβ1–4GlcNAcβ-”, using somewhat similar assays [73].”
ResultCompetition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119298 · Cited by 53
Serum antibody screening using glycan arrays
Marglous, S., Brown, C. E., Padler‐Karavani, V., Cummings, R. D., & Gildersleeve, J. C. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00693j · Cited by 32
Advanced Technologies in Sialic Acid and Sialoglycoconjugate Analysis
Kitajima, K., Varki, N. M., & Sato, C. (2013) · Topics in current chemistry · doi:10.1007/128_2013_458 · Cited by 26
“[21] and Davies and Varki [8] .”
Guthmiller, J. J., Utset, H. A., Henry, C., Li, L., Zheng, N., Sun, W., Vieira, M. C., Zost, S. J., Huang, M., Hensley, S. E., et al. (2021) · mBio · doi:10.1128/mbio.00838-21 · Cited by 20
Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?
Obukhova, P. S., Tsygankova, S., Chinarev, A. A., Shilova, N. V., Nokel, A. Y., Kosma, P., & Bovin, N. V. (2019) · Glycobiology · doi:10.1093/glycob/cwz107 · Cited by 16
Self-citationKubelková, K., & Macela, A. (2021) · Microorganisms · doi:10.3390/microorganisms9102136 · Cited by 13
Purohit, S. B., Ferris, D. G., Alvarez, M., Tran, P. M. H., Tran, L. K. H., Mysona, D., Hopkins, D., Zhi, W., Dun, B., Wallbillich, J. J., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.01.014 · Cited by 12
Dobrochaeva, K. L., Khasbiullina, N. R., Shilova, N. V., Obukhova, P. S., Knirel, Y. A., Nokel, A. Y., & Bovin, N. V. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.011 · Cited by 10
Self-citationRodríguez‐Zhurbenko, N., Quách, T. D., Rothstein, T. L., & Hernández, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1061651 · Cited by 9
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
Зиганшина, М. М., Shilova, N. V., Халтурина, Е. О., Dolgushina, N. V., Borisevich, S. V., Львовна, Я. Е., Bovin, N. V., & Sukhikh, G. T. (2023) · Viruses · doi:10.3390/v15071584 · Cited by 7
Self-citationOlasz, K., Gál, S., Khanfar, E., Balogh, P., Németh, P., Berki, T., & Boldizsár, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111683 · Cited by 6
“Because these antibodies are polyreactive, they can recognize a wide range of molecules, including glycoproteins, double-stranded DNA (dsDNA), phospholipids, glycolipids and oxidized lipids [13–15].”
BackgroundSynthesis of spacer armed Kdn(2→6') and (2→3')-lactosamines for immunochemical research
Chinarev, A. A., Sablina, M. A., Kunetskiy, R. A., Shilova, N. V., Polyakova, S. M., Paramonov, A. S., Saha, J., & Bovin, N. V. (2021) · Mendeleev Communications · doi:10.1016/j.mencom.2021.07.017 · Cited by 5
Self-citationAntibodies Against Unusual Forms of Sialylated Glycans
Obukhova, P. S., Зиганшина, М. М., Shilova, N. V., Chinarev, A. A., Pazynina, G. V., Nokel, A. Y., Terenteva, A. V., Khasbiullina, N. R., Sukhikh, G. T., Ragimov, A. A., et al. (2022) · Acta Naturae · doi:10.32607/actanaturae.11631 · Cited by 3
Self-citationSome Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System
Shilova, N. V., Nokel, A. Y., Lipatnikov, A., Khasbiullina, N. R., Knirel, Y. A., Baidakova, L. K., Tuzikov, A. B., Khaidukov, S. V., Obukhova, P. S., Henry, S. M., et al. (2024) · Antibodies · doi:10.3390/antib13040105 · Cited by 1
Self-citationObukhova, P. S., Tsygankova, S., Chinarev, A. A., Shilova, N. V., Nokel, A. Y., Kosma, P., & Bovin, N. V. (2020) · Glycobiology · doi:10.1093/glycob/cwaa004 · Cited by 1
Self-citationInvestigação dos mecanismos de ação da sílica mesoporosa nanoestruturada SBA-15 como adjuvante.
Scaramuzzi, K. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2013.tde-07062014-111900 · Cited by 2
Shilova, N. V., Ryzhov, I. M., Зиганшина, М. М., Rakitko, A., Huflejt, M. E., & Bovin, N. V. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020060291
Self-citationVital Functions of Glycans in the Biological Systems
Rani, R., Malik, P., Singh, R., Kumar, R., Patel, V. H., & Mukherjee, T. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815322521125010004
Metadata
- Authors
- Shilova, N., Huflejt, M. E., Vuskovic, M., Obukhova, P., Navakouski, M., Khasbiullina, N., Pazynina, G., Galanina, O., Bazhenov, A., & Bovin, N.
- Affiliations
- Russian Academy of Sciences (RU)
- NYU Langone Health (US)
- San Diego State University (US)
- Research Institute of Emergency Care (RU)
- Corresponding author
- Bovin, Nicolai
- ORCID
- Venue
- Topics in Current Chemistry
- Publisher
- Springer Berlin Heidelberg
- Published
- 2013
- Volume
- 366
- Pages
- 169-181
- ISSN
- 0340-1022 (ISSN-L)
- 1436-5049
- OpenAlex
- W161043586
- Cited by
- 22
- References
- 28
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 2
- FWCI
- 1.74
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Topics in current chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- natural antibodies, sialoglycans, anti-glycan antibodies, sialosides, N-glycolylneuraminic acid, gangliosides
- MeSH terms
- Antibodies, Heterophile, Antibody Specificity, Binding Sites, Antibody, Carbohydrate Sequence, Gangliosides, Glycoproteins, Humans, Immunoglobulin G, Immunity, Innate, Molecular Sequence Data, Oligosaccharides, Protein Binding, Microarray Analysis, Immunity, Humoral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.